Nahdi Medical Company
Nahdi Medical Company (4164.SR) Revenue
Annual & quarterly revenue history · segment & region breakdown
4164.SR · revenue · updated Jun 15, 2026
Core revenue metrics
Trailing 12 monthsNahdi Medical Company trailing twelve-month (TTM) revenue is $10.37B, an increase of 8.12% year-over-year from $10.21B in FY2025.
Revenue trend
2025 – 2017 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $10.21B | +$0.77B | +8.12% |
| 2024-12-31 | $9.45B | +$0.73B | +8.41% |
| 2023-12-31 | $8.71B | +$0.10B | +1.13% |
| 2022-12-31 | $8.62B | +$0.55B | +6.82% |
| 2021-12-31 | $8.07B | -$0.58B | -6.66% |
| 2020-12-31 | $8.64B | +$0.82B | +10.45% |
| 2019-12-31 | $7.82B | +$0.47B | +6.46% |
| 2018-12-31 | $7.35B | +$0.29B | +4.16% |
| 2017-12-31 | $7.06B | — | — |
Compare revenue vs peers
Medical - PharmaceuticalsCompare 4164.SR revenue against listed peers. Click any row to open that company's revenue tab.
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Nahdi Medical Company receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Nahdi Medical Company reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in SAR.
Data sourced from Nahdi Medical Company's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
4164.SR revenue · 4 questions4164.SR's trailing twelve-month (TTM) revenue is $10.37B. That is an increase of 8.12% year-over-year from $10.21B in FY2025.
▸ Source: FMP · Nahdi Medical Company SEC filings · GAAP · Nahdi Medical Company SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 15, 2026